These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [An immunohistochemical study on regional immunological response of uterine cervical cancer].
    Author: Okamoto Y.
    Journal: Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):456-62. PubMed ID: 2373918.
    Abstract:
    An immunohistochemical analysis was performed to detect MHC class I (HLA-ABC) and class II (HLA-DR) antigens expression on cancer cells from 20 patients with carcinoma of the cervix using monoclonal antibodies to HLA-ABC and DR antigens. Locally infiltrating lymphocytes were also examined with anti-Leu 1,-Leu 2a,-Leu 3a, and -Leu 12. Class I and class II antigens expression on cervical cancer cell lines OMC-1 and OMC-4 were examined in the same way, and the effects of Interferon (IFN)-gamma treatment were evaluated with Cell-EIA tests. The results were as follows. 1) Class I antigens were preserved in many cases, but lost in some. 2) Class II antigens were newly expressed in some cases. 3) Among the many infiltrating T cells, Leu 2a-positive cells were predominant in surrounding the cancer nests which preserved class I antigens, and Leu 3a-positive cells were predominant in surrounding the cancer nests which expressed class II antigens. 4) Both OMC-1 and OMC-4 cervical cancer cell lines expressed class I and class II antigens. 5) Cell-EIA tests showed that IFN-gamma treatment enhanced the expression of class I and class II antigens in OMC-1 and OMC-4. These results suggested that the preservation of class I antigens and the expression of class II antigens on cervical cancer cells markedly increase the local immune response in cervical cancer, and IFN-gamma treatment enhances the immune response in vivo.
    [Abstract] [Full Text] [Related] [New Search]